Orthopedic Surgery Doctors in Warrenton, VA Accepting Medicare

10 Orthopedic Surgery doctors found. Showing 1 - 10

Christopher J Brown, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0342

David M Snyder, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 523 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0342

Robert T Smith Jr., MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 52 West Shirley Avenue, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0492

Eleana Marie Cook, PA-C Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220

Robert C Dart, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0342

Jeffrey J Wise, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0342

Dr. James Patrick Ward, M.D. Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220

Ralph B Garretson, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0342

Louis Magdon Iii, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220

James R Ramser, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 52 W Shirley Ave, Warrenton, VA 20186 Phone: 540-347-9220    Fax: 540-347-0342

News Archive

Targeting the inflamed synovium: The quest for specificity

In the April 2006 issue of Arthritis & Rheumatism, noted rheumatology specialists with Kings College London, Dr. Toby Garrood and Dr. Costantino Pitzalis offer an overview of recent breakthroughs and a preview of future directions in this critical quest for specificity.

Mylan granted FDA approvals for generic Hyzaar and Cozaar ANDAs

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for the generic versions of Hyzaar® Tablets, 50 mg/12.5 mg and 100 mg/25 mg, and Cozaar® Tablets, 25 mg, 50 mg and 100 mg, both antihypertensives.

OncoGenex Pharmaceuticals' OGX-011 granted FDA fast track status

OncoGenex Pharmaceuticals has announced that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer.

Simulations Plus first quarter consolidated revenues increase 15.4% to record $2.811M

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, today reported financial results for its first quarter of fiscal year 2011 ended November 30, 2010 (1QFY11).

Read more Medical News

› Verified 8 days ago